LU92427I2 - Aripiprazole - Google Patents

Aripiprazole

Info

Publication number: LU92427I2
Authority: LU; Luxembourg
Prior art keywords: aripiprazole
Prior art date: 2003-10-23

Application number

LU92427C

Other languages

English (en)

Other versions

LU92427I9 (fr

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-23

Filing date

2014-04-11

Publication date

2014-06-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34549292&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92427(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-04-11 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

2014-06-11 Publication of LU92427I2 publication Critical patent/LU92427I2/fr

2019-01-17 Publication of LU92427I9 publication Critical patent/LU92427I9/fr

Links

CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 title 1
229960004372 aripiprazole Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

LU92427C 2003-10-23 2014-04-11 Aripiprazole LU92427I2 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US51361803P	2003-10-23	2003-10-23

Publications (2)

Publication Number	Publication Date
LU92427I2 true LU92427I2 (fr)	2014-06-11
LU92427I9 LU92427I9 (fr)	2019-01-17

Family

ID=34549292

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU92427C LU92427I2 (fr)	2003-10-23	2014-04-11	Aripiprazole

Country Status (32)

Country	Link
US (12)	US7807680B2 (fr)
EP (1)	EP1675573B2 (fr)
JP (2)	JP4836797B2 (fr)
KR (1)	KR100931784B1 (fr)
CN (1)	CN1870980B (fr)
AR (2)	AR046141A1 (fr)
AT (1)	ATE411797T2 (fr)
AU (1)	AU2004285448C1 (fr)
BR (1)	BRPI0415531B8 (fr)
CA (1)	CA2543242C (fr)
CO (1)	CO5690539A2 (fr)
CY (2)	CY1109040T1 (fr)
DE (1)	DE602004017342D1 (fr)
DK (1)	DK1675573T4 (fr)
EC (2)	ECSP066512A (fr)
ES (1)	ES2315721T5 (fr)
FR (1)	FR14C0039I1 (fr)
GE (1)	GEP20115205B (fr)
IL (1)	IL175072A (fr)
LU (1)	LU92427I2 (fr)
MX (1)	MXPA06004489A (fr)
MY (1)	MY146093A (fr)
NO (2)	NO334919B1 (fr)
NZ (1)	NZ546063A (fr)
PE (1)	PE20050811A1 (fr)
PL (1)	PL1675573T4 (fr)
PT (1)	PT1675573E (fr)
SI (1)	SI1675573T2 (fr)
TW (2)	TWI383810B (fr)
UA (1)	UA82561C2 (fr)
WO (1)	WO2005041937A2 (fr)
ZA (1)	ZA200602347B (fr)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR033485A1 (es)	2001-09-25	2003-12-26	Otsuka Pharma Co Ltd	Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
US20050032811A1 (en) *	2003-08-06	2005-02-10	Josiah Brown	Methods for administering aripiprazole
BRPI0415531B8 (pt) *	2003-10-23	2021-05-25	Otsuka Pharma Co Ltd	formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação
WO2006053781A1 (fr) *	2004-11-18	2006-05-26	Synthon B.V.	Procédé de synthèse d'aripiprazole cristallin
WO2007035348A2 (fr) *	2005-09-15	2007-03-29	Elan Pharma International, Limited	Formulations aripiprazoliques nanoparticulaires
US8158152B2 (en) *	2005-11-18	2012-04-17	Scidose Llc	Lyophilization process and products obtained thereby
WO2007081367A1 (fr) *	2006-01-05	2007-07-19	Teva Pharmaceutical Industries Ltd.	Formulations seches d'aripiprazole
DK1808164T3 (da)	2006-01-05	2009-04-20	Teva Pharma	Vådgranuleringsmetode til fremstilling af farmaceutiske sammensætninger af aripiprazol
TR200604349A2 (tr) *	2006-08-15	2008-03-21	NOBEL İLAÇ SANAYii VE TiCARET A.Ş.	Aripiprazol içeren farmasötik bileşimler
GB0618879D0 (en) *	2006-09-26	2006-11-01	Zysis Ltd	Pharmaceutical compositions
KR101892745B1 (ko) *	2007-06-25	2018-08-28	오쓰까 세이야꾸 가부시키가이샤	코어/셀 구조를 가진 미소구
LT2170279T (lt) *	2007-07-31	2018-03-12	Otsuka Pharmaceutical Co., Ltd.	Aripiprazolo suspensijos ir liofilizuotos kompozicijos gamybos būdai
JP6072539B2 (ja)	2009-05-27	2017-02-01	アルカーメスファーマアイルランドリミテッド	ナノ粒子活性物質組成物におけるフレーク状凝集の軽減
KR101125210B1 (ko) *	2009-09-11	2012-03-19	주식회사 대웅제약	아리피프라졸-벤토나이트-ａｅａ 혼성체, 이를 함유하는 약학 조성물 및 그 제조방법
CN103284968B (zh) *	2010-04-13	2015-11-18	齐鲁制药有限公司	一种阿立哌唑组合物微晶的口腔崩解片及其制备方法
IL206739A (en) *	2010-06-30	2016-06-30	David Segal	An injectable drug containing silitol as an active substance
JP5575269B2 (ja)	2010-08-24	2014-08-20	大塚製薬株式会社	カルボスチリル誘導体並びにシリコーンオイル及び／又はシリコーンオイル誘導体を含有する懸濁液及びケーキ組成物
US9469630B2 (en)	2010-10-18	2016-10-18	Sumitomo Dainippon Pharma Co., Ltd.	Sustained-release formulation for injection
CN103491961B (zh) *	2010-10-28	2018-01-02	艾库斯制药有限公司	阿立哌唑组合物和用于其经皮给药的方法
US9757374B2 (en) *	2010-10-28	2017-09-12	Aequus Pharmaceuticals Inc.	Aripiprazole compositions and methods for its transdermal delivery
AR083884A1 (es)	2010-11-16	2013-03-27	Otsuka Pharma Co Ltd	Jeringa prellenable de doble camara y relleno de aripiprazol en la jeringa
CN102525915B (zh) *	2010-12-14	2016-09-28	江苏豪森药业集团有限公司	一种持续释放的注射制剂及其制备方法和用途
CN105125509B (zh)	2011-01-24	2019-01-11	大塚制药株式会社	以阿立哌唑作为有效成分的块状组合物
ES2972387T3 (es)	2011-03-18	2024-06-12	Alkermes Pharma Ireland Ltd	Composiciones farmacéuticas que comprenden ésteres de sorbitán
JO3410B1 (ar) *	2011-06-07	2019-10-20	Otsuka Pharma Co Ltd	تركيبة أريبيبرازول مجفف بالتبريد
US9241876B2 (en) *	2011-06-27	2016-01-26	Shanghai Zhongxi Pharmaceutical Corporation	Aripiprazole medicament formulation and preparation method therefor
CN102850268B (zh) *	2011-06-27	2015-07-15	上海中西制药有限公司	阿立哌唑ⅰ型微晶、阿立哌唑固体制剂及制备方法
WO2013142202A1 (fr)	2012-03-19	2013-09-26	Alkermes Pharma Ireland Limited	Compositions pharmaceutiques comprenant des esters de glycérol
US9999670B2 (en)	2012-03-19	2018-06-19	Alkermes Pharma Ireland Limited	Pharmaceutical compositions comprising benzyl alcohol
CA2867121C (fr) *	2012-03-19	2021-05-25	Alkermes Pharma Ireland Limited	Compositions pharmaceutiques comprenant des esters d'acides gras
AR090775A1 (es) *	2012-04-23	2014-12-03	Otsuka Pharma Co Ltd	Preparado inyectable
TWI562991B (en)	2012-04-23	2016-12-21	Otsuka Pharma Co Ltd	Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same
JOP20200109A1 (ar)	2012-04-23	2017-06-16	Otsuka Pharma Co Ltd	مستحضر قابل للحقن
JP2015529199A (ja) *	2012-08-21	2015-10-05	オルソ−クリニカルダイアグノスティクス，インコーポレイティド	パリペリドンハプテンに対する抗体及びその使用
EP2888277A4 (fr)	2012-08-21	2016-05-18	Ortho Clinical Diagnostics Inc	Anticorps dirigés contre la palipéridone et leur utilisation
WO2014031645A1 (fr)	2012-08-21	2014-02-27	Ortho-Clinical Diagnostics, Inc	Anticorps dirigés contre des haptènes de rispéridone et leur utilisation
ES2870004T3 (es) *	2012-08-21	2021-10-26	Janssen Pharmaceutica Nv	Anticuerpos contra la risperidona y uso de los mismos
PL2888286T3 (pl)	2012-08-21	2018-07-31	Janssen Pharmaceutica Nv	Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie
ES2654413T3 (es)	2012-08-21	2018-02-13	Janssen Pharmaceutica, N.V.	Anticuerpos a quetiapina y uso de los mismos
JP6654042B2 (ja)	2012-09-19	2020-02-26	アルカームスファーマアイルランドリミテッド	貯蔵安定性が改善された医薬組成物
ES2625613T3 (es) *	2013-04-30	2017-07-20	Otsuka Pharmaceutical Co., Ltd.	Preparación sólida oral que comprende aripiprazol y método para producir una preparación sólida oral que comprende aripiprazol
US9051268B2 (en)	2013-04-30	2015-06-09	Otsuka Pharmaceutical Co., Ltd.	Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole
US10525057B2 (en)	2013-09-24	2020-01-07	Otsuka Pharmaceutical Co., Ltd.	Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
AU2015231278B2 (en) *	2014-03-20	2020-01-23	Alkermes Pharma Ireland Limited	Aripiprazole formulations having increased injection speeds
SMT202100481T1 (it)	2014-08-18	2021-09-14	Alkermes Pharma Ireland Ltd	Composizioni per profarmaci di aripiprazolo
US10016415B2 (en)	2014-08-18	2018-07-10	Alkermes Pharma Ireland Limited	Aripiprazole prodrug compositions
SMT202100212T1 (it) *	2014-08-25	2021-07-12	Alkermes Pharma Ireland Ltd	Processo di cristallizzazione di derivati di aripiprazolo in formulazioni a rilascio prolungato per il trattamento di schizofrenia
WO2016189504A1 (fr) *	2015-05-28	2016-12-01	Leiutis Pharmaceuticals Pvt Ltd	Compositions non lyophilisée d'aripiprazole et procédés de préparation de celles-ci
TWI584823B (zh) *	2015-08-31	2017-06-01	諾瑞特國際藥業股份有限公司	具有延長的保存期限的阿立哌唑可注射懸浮液製劑
CN106474058B (zh) *	2015-08-31	2020-01-07	南京诺瑞特医药科技有限公司	具有延长的保质期的阿立哌唑可注射悬浮液制剂
JP6504019B2 (ja) *	2015-10-27	2019-04-24	豊田合成株式会社	発光装置
JP6949025B2 (ja)	2015-12-17	2021-10-13	ヤンセンファーマシューティカエヌ．ベー．	リスペリドンに対する抗体及びその使用
CN108368180B (zh)	2015-12-17	2022-07-26	詹森药业有限公司	喹硫平的抗体及其用途
CN105663057A (zh) *	2015-12-30	2016-06-15	中国药科大学	阿立哌唑长效混悬剂及其制备方法
US20190160002A1 (en) *	2016-07-28	2019-05-30	Mylan Laboratories Limited	Process for preparing sterile aripiprazole formulation
AU2019230014B2 (en)	2018-03-05	2024-11-28	Alkermes Pharma Ireland Limited	Aripiprazole dosing strategy
CN108498456B (zh)	2018-05-16	2021-01-01	丽珠医药集团股份有限公司	一种阿立哌唑缓释微球及其制备方法
CN110327296B (zh) *	2019-08-06	2021-10-22	深圳市泛谷药业股份有限公司	一种阿立哌唑长效注射制剂及其制备方法
KR102486564B1 (ko) *	2019-08-23	2023-01-19	주식회사 대웅테라퓨틱스	니클로사마이드 지연방출 조성물 및 이의 항바이러스 용도
PH12022550448A1 (en)	2019-08-23	2022-12-12	Daewoong Pharmaceutical Co Ltd	Niclosamide delayed-release composition and antiviral use thereof
EP4087542A4 (fr) *	2020-01-06	2023-12-20	Shilpa Medicare Limited	Suspension injectable à libération prolongée de fingolimod
WO2021199076A1 (fr)	2020-03-30	2021-10-07	Cipla Limited	Formulation d'aripiprazole injectable
US20230129919A1 (en)	2020-04-01	2023-04-27	Otsuka Pharmaceutical Co., Ltd.	Methods for dose initiation of aripiprazole treatments
KR102606504B1 (ko) *	2020-04-10	2023-11-29	주식회사 대웅테라퓨틱스	니클로사마이드를 포함하는 폐고혈압의 예방 및 치료용 조성물
WO2021233402A1 (fr) *	2020-05-21	2021-11-25	江苏先声药业有限公司	Composition pharmaceutique contenant du brexpiprazole et son procédé de préparation
KR102785446B1 (ko) *	2020-09-09	2025-03-25	주식회사 대웅테라퓨틱스	니클로사마이드를 포함하는 항인플루엔자 바이러스용 조성물
CN112656761B (zh) *	2020-12-30	2023-09-08	河南合智医药科技有限公司	一种低刺激性阿立哌唑前药的油溶缓释注射制剂及其制备方法
EP4043008A1 (fr)	2021-02-15	2022-08-17	Warszawskie Zaklady Farmaceutyczne Polfa S.A.	Procédé de préparation d'une composition pharmaceutique comprenant de l'aripiprazole
HUP2100259A1 (hu)	2021-07-07	2023-01-28	Richter Gedeon Nyrt	Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények
JP2024016759A (ja) *	2022-07-26	2024-02-07	ニプロ株式会社	アリピプラゾール懸濁液の製造方法
CN115554253B (zh) *	2022-10-14	2024-03-29	浙江圣兆药物科技股份有限公司	一种平稳释药的注射用阿立哌唑冻干制剂及其制备方法
GR1010624B (el) *	2023-03-23	2024-01-30	Φαρματεν Α.Β.Ε.Ε.,	Φαρμακευτικο σκευασμα που περιλαμβανει αριπιπραζολη και μεθοδος για την παρασκευη αυτου
GR1010656B (el) *	2023-03-23	2024-03-21	Φαρματεν Α.Β.Ε.Ε.,	Φαρμακευτικο σκευασμα που περιλαμβανει εναν ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου
CN120957722A (zh)	2023-04-26	2025-11-14	大塚制药株式会社	用阿立哌唑治疗精神分裂症或i型双相障碍的剂量启动

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB209551A (en)	1922-11-20	1924-01-17	William Mortimer Melmore	Improvements in or relating to petrol and other cans
US4038389A (en)	1975-05-07	1977-07-26	The Upjohn Company	Medroxyprogesterone acetate compositions
JPS54130587A (en)	1978-03-30	1979-10-09	Otsuka Pharmaceut Co Ltd	Carbostyryl derivative
CA1209477A (fr)	1981-03-26	1986-08-12	Bruce E. Haeger	Compose comprenant une preparation lyophilisee de derive de la penicilline
JPS5832899A (ja)	1981-08-18	1983-02-25	Takeda Chem Ind Ltd	オキセンドロン水性懸濁剤
US4352811A (en)	1981-11-12	1982-10-05	Hoechst-Roussel Pharmaceuticals Inc.	3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
IL68549A (en) *	1983-05-03	1988-05-31	Kit Medidont Ltd	Method and instrument for measuring moisture
KR850004274A (ko)	1983-12-13	1985-07-11	원본미기재	에리트로포이에틴의 제조방법
US4804663A (en)	1985-03-27	1989-02-14	Janssen Pharmaceutica N.V.	3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
JP2608788B2 (ja) *	1988-10-31	1997-05-14	大塚製薬株式会社	精神分裂病治療剤
US5006528A (en) *	1988-10-31	1991-04-09	Otsuka Pharmaceutical Co., Ltd.	Carbostyril derivatives
JPH03212852A (ja)	1990-01-18	1991-09-18	Hitachi Electron Eng Co Ltd	記録媒体カートリッジ搬送装置における送り機構
FR2663223B1 (fr)	1990-06-14	1994-12-02	Af Aplicaciones Far Lab	Forme galenique parenterale.
JP3282731B2 (ja)	1990-06-15	2002-05-20	メルクエンドカムパニーインコーポレーテッド	結晶の構造および大きさを改良する結晶化方法
IT1244880B (it)	1990-12-11	1994-09-12	Torre A Farmaceutici	Formulazioni di amminoacidi liofilizzati contenenti glutammina, loro preparazione ed uso nell'alimentazione parenterale
US6193983B1 (en)	1992-06-01	2001-02-27	The University Of Melbourne	Equine herpesvirus glycoproteins
TW376319B (en)	1993-04-28	1999-12-11	Janssen Pharmaceutica Nv	Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
ATE288270T1 (de)	1993-11-19	2005-02-15	Janssen Pharmaceutica Nv	Mikroverkapselte 1,2-benzazole
JP4142095B2 (ja)	1994-06-02	2008-08-27	クアドラント・ドラツグ・デリバリー・リミテツド	各種物質の再水和または融解時の凝集を防止する方法及び該方法により得られる組成物
RU2082401C1 (ru)	1994-08-18	1997-06-27	Фармацевтическое акционерное общество "Ферейн"	Способ получения лекарственной формы комбинированного препарата
US6165442A (en)	1996-02-19	2000-12-26	Nycomed Imaging As	Thermally stabilized ultrasound contrast agent
TW487572B (en)	1996-05-20	2002-05-21	Janssen Pharmaceutica Nv	Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
EP0941066B1 (fr)	1996-08-26	2003-10-29	Transgene S.A.	Complexes acides nucleiques/lipides cationiques
US6297231B1 (en)	1996-10-28	2001-10-02	Merck & Co., Inc.	Stabilized carbapenem antibiotic compositions and method of making
GB9705588D0 (en) *	1997-03-18	1997-05-07	Anglia Research Foundation	Stable particle in liquid formulations
GB9718986D0 (en)	1997-09-09	1997-11-12	Danbiosyst Uk	Controlled release microsphere delivery system
UA72189C2 (uk)	1997-11-17	2005-02-15	Янссен Фармацевтика Н.В.	Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
ATE355856T1 (de)	1998-07-30	2007-03-15	Point Biomedical Corp	Neuer wirkstoffträger für die gefriertrocknung von wässrigen suspensionen von mikropartikeln
DE19857609A1 (de)	1998-12-14	2000-06-15	Hannelore Ehrenreich	Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
US6455526B1 (en)	1998-12-16	2002-09-24	Aventis Pharmaceuticals, Inc.	Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
US6267989B1 (en)	1999-03-08	2001-07-31	Klan Pharma International Ltd.	Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
ATE296806T1 (de)	1999-12-09	2005-06-15	Syngenta Participations Ag	Pyrazolcarboxamide und pyrazolthioamide als fungizide
JP2001187735A (ja) *	2000-01-05	2001-07-10	Towa Yakuhin Kk	安定なニコランジル含有粉末の製造法
US6559128B1 (en)	2000-01-21	2003-05-06	Northwestern University	Inhibitors of G protein-mediated signaling, methods of making them, and uses thereof
RU2169574C1 (ru)	2000-01-27	2001-06-27	Кобатов Алексей Иванович	Способ получения биопрепарата и сухой биопрепарат
WO2001058428A1 (fr)	2000-02-10	2001-08-16	Alkermes Controlled Therapeutics, Inc.	Procede de preparation d'une composition a liberation prolongee
CN1229339C (zh)	2000-03-27	2005-11-30	斯克里普斯研究学院	抑制血管生成和肿瘤生长的化合物，含有该化合物的药用制剂，以及该化合物的制药用途
AU4477001A (en)	2000-04-18	2001-10-30	Peptron Inc.	Injectable sustained release pharmaceutical composition and processes for preparing the same
US6495164B1 (en)	2000-05-25	2002-12-17	Alkermes Controlled Therapeutics, Inc. I	Preparation of injectable suspensions having improved injectability
JP2002241284A (ja) *	2001-02-16	2002-08-28	Towa Yakuhin Kk	全身投与用アルガトロバン注射液
MY129350A (en) *	2001-04-25	2007-03-30	Bristol Myers Squibb Co	Aripiprazole oral solution
JP2003063965A (ja) *	2001-06-13	2003-03-05	Otsuka Pharmaceut Factory Inc	注射用シロスタゾール水性製剤
CN100350977C (zh)	2001-06-14	2007-11-28	大塚制药株式会社	药物组合物
US20050019399A1 (en)	2001-09-21	2005-01-27	Gina Fischer	Controlled release solid dispersions
PE20030445A1 (es) *	2001-09-25	2003-07-26	Otsuka Pharma Co Ltd	Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
AR033485A1 (es) *	2001-09-25	2003-12-26	Otsuka Pharma Co Ltd	Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
ITMI20020808A1 (it)	2002-04-17	2003-10-17	Chiesi Farma Spa	Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
GB0216416D0 (en)	2002-07-15	2002-08-21	Novartis Ag	Organic compounds
EP2283864A1 (fr) *	2002-07-16	2011-02-16	Elan Pharma International Ltd.	Composition liquide contenant des nanoparticules stabilisées d'une substance active
NZ537995A (en) *	2002-08-20	2007-11-30	Bristol Myers Squibb Co	Inclusion complex of aripiprazole in a substituted b-cyclodextrin
US7658998B2 (en) *	2003-01-22	2010-02-09	Alkermes Controlled Therapeutics, Inc.	Method of preparing sustained release microparticles
US20050032811A1 (en) *	2003-08-06	2005-02-10	Josiah Brown	Methods for administering aripiprazole
US6987111B2 (en)	2003-08-06	2006-01-17	Alkermes Controlled Therapeutics, Ii	Aripiprazole, olanzapine and haloperidol pamoate salts
BRPI0415531B8 (pt)	2003-10-23	2021-05-25	Otsuka Pharma Co Ltd	formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação
CA2543296A1 (fr)	2003-10-31	2005-05-12	Point Biomedical Corporation	Compositions de microspheres reconstitutables utilisees en tant qu'agents de contraste ultrasonores

2004
- 2004-10-18 BR BRPI0415531A patent/BRPI0415531B8/pt not_active IP Right Cessation
- 2004-10-18 CA CA2543242A patent/CA2543242C/fr not_active Expired - Lifetime
- 2004-10-18 ES ES04795514T patent/ES2315721T5/es not_active Expired - Lifetime
- 2004-10-18 PL PL04795514T patent/PL1675573T4/pl unknown
- 2004-10-18 MX MXPA06004489A patent/MXPA06004489A/es active IP Right Grant
- 2004-10-18 JP JP2006536693A patent/JP4836797B2/ja not_active Expired - Lifetime
- 2004-10-18 DK DK04795514.1T patent/DK1675573T4/da active
- 2004-10-18 UA UAA200604046A patent/UA82561C2/uk unknown
- 2004-10-18 CN CN2004800308144A patent/CN1870980B/zh not_active Expired - Lifetime
- 2004-10-18 GE GEAP20049360A patent/GEP20115205B/en unknown
- 2004-10-18 WO PCT/US2004/034367 patent/WO2005041937A2/fr not_active Ceased
- 2004-10-18 SI SI200430966T patent/SI1675573T2/sl unknown
- 2004-10-18 AU AU2004285448A patent/AU2004285448C1/en active Active
- 2004-10-18 EP EP04795514A patent/EP1675573B2/fr not_active Expired - Lifetime
- 2004-10-18 KR KR1020067007890A patent/KR100931784B1/ko not_active Expired - Lifetime
- 2004-10-18 PT PT04795514T patent/PT1675573E/pt unknown
- 2004-10-18 ZA ZA200602347A patent/ZA200602347B/en unknown
- 2004-10-18 DE DE602004017342T patent/DE602004017342D1/de not_active Expired - Lifetime
- 2004-10-18 AT AT04795514T patent/ATE411797T2/de active
- 2004-10-18 NZ NZ546063A patent/NZ546063A/en not_active IP Right Cessation
- 2004-10-19 US US10/968,482 patent/US7807680B2/en not_active Expired - Lifetime
- 2004-10-20 TW TW093131836A patent/TWI383810B/zh not_active IP Right Cessation
- 2004-10-20 TW TW100136057A patent/TWI421101B/zh not_active IP Right Cessation
- 2004-10-22 AR ARP040103849A patent/AR046141A1/es not_active Application Discontinuation
- 2004-10-22 MY MYPI20044358A patent/MY146093A/en unknown
- 2004-10-25 PE PE2004001021A patent/PE20050811A1/es active IP Right Grant
2006
- 2006-04-18 EC EC2006006512A patent/ECSP066512A/es unknown
- 2006-04-19 CO CO06036842A patent/CO5690539A2/es active IP Right Grant
- 2006-04-20 IL IL175072A patent/IL175072A/en not_active IP Right Cessation
- 2006-05-22 NO NO20062319A patent/NO334919B1/no active Protection Beyond IP Right Term
2007
- 2007-08-17 US US11/889,935 patent/US20080221121A1/en not_active Abandoned
- 2007-10-31 US US11/979,149 patent/US8030313B2/en active Active
- 2007-10-31 US US11/979,144 patent/US20080112985A1/en not_active Abandoned
- 2007-10-31 US US11/979,145 patent/US8722679B2/en not_active Expired - Fee Related
2008
- 2008-12-31 CY CY20081101518T patent/CY1109040T1/el unknown
2011
- 2011-01-14 JP JP2011006037A patent/JP5372032B2/ja not_active Expired - Lifetime
- 2011-12-28 US US13/338,827 patent/US8952013B2/en not_active Expired - Lifetime
2012
- 2012-01-20 EC EC2012006512A patent/ECSP12006512A/es unknown
2013
- 2013-09-19 US US14/031,571 patent/US20140018369A1/en not_active Abandoned
2014
- 2014-04-11 LU LU92427C patent/LU92427I2/fr unknown
- 2014-05-13 FR FR14C0039C patent/FR14C0039I1/fr active Active
- 2014-05-13 CY CY2014021C patent/CY2014021I2/el unknown
- 2014-10-06 US US14/507,303 patent/US9763935B2/en not_active Expired - Fee Related
- 2014-10-27 NO NO2014027C patent/NO2014027I1/no not_active IP Right Cessation
2016
- 2016-10-21 AR ARP160103230A patent/AR106449A2/es not_active Application Discontinuation
2017
- 2017-08-18 US US15/680,291 patent/US20170348308A1/en not_active Abandoned
2019
- 2019-10-30 US US16/668,008 patent/US20200061057A1/en not_active Abandoned
2021
- 2021-07-16 US US17/377,898 patent/US20210338663A1/en not_active Abandoned
2024
- 2024-04-10 US US18/631,828 patent/US20240261280A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2005041937A2 (fr)	2005-05-12
SI1675573T1 (sl)	2009-02-28
TWI383810B (zh)	2013-02-01
CA2543242C (fr)	2015-04-14
ES2315721T9 (es)	2015-11-05
IL175072A0 (en)	2006-08-20
AR046141A1 (es)	2005-11-23
CN1870980B (zh)	2010-06-23
PL1675573T3 (pl)	2009-04-30
UA82561C2 (uk)	2008-04-25
KR100931784B1 (ko)	2009-12-14
US8030313B2 (en)	2011-10-04
JP4836797B2 (ja)	2011-12-14
ATE411797T2 (de)	2008-11-15
US20240261280A1 (en)	2024-08-08
CY2014021I1 (el)	2014-07-02
TW200524638A (en)	2005-08-01
US20080107745A1 (en)	2008-05-08
LU92427I9 (fr)	2019-01-17
DE602004017342D1 (de)	2008-12-04
MXPA06004489A (es)	2006-06-20
PT1675573E (pt)	2008-12-30
HK1095266A1 (zh)	2007-05-04
US20080112986A1 (en)	2008-05-15
RU2006109111A (ru)	2007-09-27
EP1675573A2 (fr)	2006-07-05
PL1675573T4 (pl)	2016-04-29
NZ546063A (en)	2009-05-31
US20210338663A1 (en)	2021-11-04
NO2014027I1 (no)	2014-11-10
ES2315721T3 (es)	2009-04-01
CO5690539A2 (es)	2006-10-31
ECSP12006512A (es)	2012-02-29
AU2004285448C1 (en)	2021-08-19
CY2014021I2 (el)	2017-03-15
US20050148597A1 (en)	2005-07-07
BRPI0415531B8 (pt)	2021-05-25
NO2014027I2 (no)	2014-10-27
PL1675573T5 (pl)	2012-10-31
AU2004285448A1 (en)	2005-05-12
US20150024056A1 (en)	2015-01-22
JP2007509148A (ja)	2007-04-12
NO20062319L (no)	2006-07-21
US8722679B2 (en)	2014-05-13
US20140018369A1 (en)	2014-01-16
FR14C0039I1 (fr)	2014-06-27
US9763935B2 (en)	2017-09-19
CA2543242A1 (fr)	2005-05-12
DK1675573T3 (da)	2009-01-05
BRPI0415531A (pt)	2006-12-26
RU2342927C2 (ru)	2009-01-10
AR106449A2 (es)	2018-01-17
KR20060118450A (ko)	2006-11-23
ECSP066512A (es)	2006-10-10
US20200061057A1 (en)	2020-02-27
US20120100190A1 (en)	2012-04-26
BRPI0415531B1 (pt)	2019-07-30
PE20050811A1 (es)	2005-09-25
MY146093A (en)	2012-06-29
ES2315721T5 (es)	2012-08-24
JP5372032B2 (ja)	2013-12-18
ZA200602347B (en)	2007-09-26
NO334919B1 (no)	2014-07-14
SI1675573T2 (sl)	2012-08-31
US20080221121A1 (en)	2008-09-11
JP2011102316A (ja)	2011-05-26
WO2005041937A3 (fr)	2006-04-06
EP1675573B2 (fr)	2012-06-13
CY1109040T1 (el)	2014-07-02
TWI421101B (zh)	2014-01-01
IL175072A (en)	2015-06-30
DK1675573T4 (da)	2012-08-06
US20080112985A1 (en)	2008-05-15
US20170348308A1 (en)	2017-12-07
TW201204413A (en)	2012-02-01
US7807680B2 (en)	2010-10-05
AU2004285448B2 (en)	2009-06-11
EP1675573B1 (fr)	2008-10-22
US8952013B2 (en)	2015-02-10
CN1870980A (zh)	2006-11-29
GEP20115205B (en)	2011-04-26

Publication	Publication Date	Title
NO2014027I2 (no)	2014-10-27	aripiprazol
ATE363383T1 (de)	2007-06-15	Schlingenware
DE502004011955D1 (de)	2011-01-13	Doppelkuppllungsgetriebe
DE502004001683D1 (de)	2006-11-16	Kabelführung
DE60319796D1 (de)	2008-04-30	tsdetektion
DE602004008426D1 (de)	2007-10-04	Airbagfaltverfahren
FR2862675B1 (fr)	2011-04-29	Defonceuse
DE602004000258D1 (de)	2006-01-26	Einhebelwasserarmatur
DE602004013661D1 (de)	2008-06-26	Spritzgiessnadelverschlussbuchse
NO20030752D0 (no)	2003-02-17	Bölgedempningsanordning
DE502004002978D1 (de)	2007-04-05	N-biarylamide
DE602004009257D1 (de)	2007-11-15	Bremsschlauchanordung
DE602004010064D1 (de)	2007-12-27	Freilaufkupplungsfeder
DE602004025937D1 (de)	2010-04-22	2-aminobenzoylderivate
DE50305802D1 (de)	2007-01-04	Stanz-prägeniet
FR2864125B1 (fr)	2007-07-20	Caillebotis
DE602004008040D1 (de)	2007-09-20	Natrium-kobaltoxid-hydrat
DE502004007959D1 (de)	2008-10-09	Prolinylarylacetamide
DE20317661U1 (de)	2005-03-24	Faltkleiderschrank
DE602004029759D1 (de)	2010-12-09	Wälzkörperschraubvorrichtung
DE502004012392D1 (de)	2011-05-26	Wischarmgelenkvorrichtung
FI6598U1 (fi)	2005-03-07	Kantopoimuri
FR2861254B1 (fr)	2008-10-31	Ecuelle
DE10301689B4 (de)	2005-10-20	Knochenpositionierinstrument
DZ3428A1 (fr)	2005-07-02	Torrefacteur electromenager